Search

everythinglearnresearchcommunity

for

Search:↓

Chloroquine and cinchonine relax rat blood vessels by affecting calcium channels, with chloroquine needing caution in heart patients.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Blocking certain receptors in the lungs might help treat a specific type of asthma.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Upadacitinib effectively treats pyoderma gangrenosum.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Potassium channel openers like minoxidil boost hair growth.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

MK-386 reduces sebum DHT levels.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Sphingosine 1-phosphate helps control mechanical pain.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Minoxidil may protect the brain from damage by preventing cell death and energy loss.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Blocking mTORC1 reduces skin tumor growth in mice.

HSD11b1 affects skin nerves and increases non-histaminergic itch.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Calancardin B may help reduce inflammation in immune cells.